Aspirin alone for patients with lacunar stroke - 5
Narrator: This is NIH health matters, I’m Joe Balintfy. In recent clinical trials, a combination of aspirin and other antiplatelet drugs have shown promise. Dr. Walter Koroshetz at NIH explains.
Koroshetz: In heart disease, particularly in patients who have had stents or heart attacks, the combination has been shown to be superior to aspirin alone and that was the kind of the basis for the trial going forward.
Narrator: A recent trial of more than 3,000 patients with small vessel stroke tested aspirin combined with the drug clopidogrel. Results show the combination is no better than aspirin alone. For more on this study, and to learn more about strokes and stroke risk, visit the website stroke.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Audio
NIH Audio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Audio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Audio is a service of the Office of Communications & Public Liaison.